| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biochemistry |
Divisions of Molecular Epidemiology [B. F. C., F. F. K.], and Biochemical Toxicology [D. R. D., M. I. C.], National Center for Toxicological Research, Jefferson, Arkansas 72079; Division of Epidemiology, University of Minnesota, Minneapolis, Minnesota 55454 [K. E. A.]; Department of Surgery, University of Arkansas for Medical Sciences and Arkansas Cancer Research Center, Little Rock, Arkansas 72205 [N.P.L.]: and Surgery Services, Central Arkansas Veterans Health Care System, Little Rock, Arkansas 72205 [N. P. L.]
Analysis of glutathione S-transferases (GSTs) of the
alpha, mu, and pi classes by reverse-phase high-performance liquid
chromatography and electrospray-ionization mass spectrometry in 43
samples of normal human pancreas demonstrated a wide variation in
expression of subunits P1, A1, A2, A4, M1, M2, and M3 and the presence
of a novel form designated GST "A5." GSTA2 consisted of three forms
that were differentially expressed between individuals in a manner
consistent with allelic polymorphism at the hGSTA2
locus. Expression, in terms of µg GST subunit/mg cytosolic protein,
varied by 615-fold for subunits P1, A2, and M3 and 1730-fold in the
case of GSTs A1 and M2. Less consistently expressed were GSTs M1a, M1b,
A4, and A5. Among these, GSTM1 expression (excluding M1-null samples)
varied 12-fold between samples, whereas GST A4 and A5 expression varied
50100-fold between samples, well beyond the range of other
subunits, suggesting that their expression is highly inducible. Linear
correlations (P < 0.0010.003) existed
between levels of the most consistently expressed GST, GSTP1, and total
GSTs, GSTA2 and M3, and in GSTM1-positive samples, between GSTM1, M3,
and P1. The correlation between GST subunits P1 and M3 was bimodal
according to M1 genotype, reflecting the presence of the
regulatory element in hGSTM3*B that is linked with the
hGSTM1*A genotype. It is concluded that although a
degree of regulation of expression of GSTs occurs in human pancreas,
the variability of phenotype is high and might obscure the effects of
genetic polymorphisms on individual cancer susceptibility.
Interindividual variation of GST expression is, therefore, a factor
that should be taken account of in epidemiological studies.
This article has been cited by other articles:
![]() |
A. Primavera, S. Fustinoni, A. Biroccio, S. Ballerini, A. Urbani, S. Bernardini, G. Federici, E. Capucci, M. Manno, and M. Lo Bello Glutathione Transferases and Glutathionylated Hemoglobin in Workers Exposed to Low Doses of 1,3-Butadiene Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3004 - 3012. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gemignani, S. Landi, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, L. Foretova, V. Janout, et al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes Carcinogenesis, June 1, 2007; 28(6): 1287 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Dasgupta, P. J. Adamson, F. E. Davies, S. Rollinson, P. L. Roddam, A. J. Ashcroft, A. M. Dring, J. A. L. Fenton, J. A. Child, J. M. Allan, et al. Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma Blood, October 1, 2003; 102(7): 2345 - 2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ahsan and A. G. Rundle Measures of genotype versus gene products: promise and pitfalls in cancer prevention Carcinogenesis, September 1, 2003; 24(9): 1429 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Duell, E. A. Holly, P. M. Bracci, M. Liu, J. K. Wiencke, and K. T. Kelsey A Population-Based, Case-Control Study of Polymorphisms in Carcinogen-Metabolizing Genes, Smoking, and Pancreatic Adenocarcinoma Risk J Natl Cancer Inst, February 20, 2002; 94(4): 297 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Loktionov, M. A. Watson, M. Gunter, W. S.L. Stebbings, C. T.M. Speakman, and S. A. Bingham Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor Carcinogenesis, July 1, 2001; 22(7): 1053 - 1060. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |